
Is Shell Sizing Up Oil's Biggest Power Grab Yet?
BP's weak first-quarter results and stock underperformance over the past year rekindled speculation that the UK-based supermajor could be a target of a blockbuster acquisition. As it has been speculated on and off for decades, UK peer Shell could be the most likely buyer, according to recent market talk.
Speculation about another oil giant taking over BP is not new—such rumors have been swirling for over a decade, particularly ones suggesting that Shell could be the bidder for a merger with BP.
Speculation about a blockbuster acquisition involving BP resurfaced again this year after activist hedge fund Elliott bought nearly 5% in the UK-based supermajor and demanded changes, big and fast.
BP's shares have underperformed the stocks of the other four of the Big Oil group – Shell, TotalEnergies, ExxonMobil, and Chevron – ever since 2020.
Neither former BP CEO Bernard Looney, with the push toward renewables, nor his successor Murray Auchincloss, with the strategy reset to return on the path of oil and gas, have managed to erase the company's underperformance in the past five years.
After BP reported the weakest set of Q1 results among Big Oil and reduced by $1 billion its quarterly share buyback program as cash flow declined and net debt rose, speculation of a Shell-BP megadeal intensified.This week, Bloomberg reported that Shell is considering the merits of a takeover bid for BP, which has seen its fortunes dim recently after its rather premature bet on a fast energy transition.
Unnamed sources familiar with the developments have told Bloomberg that Shell was studying a takeover that would depend on whether the BP stock would continue to decline after losing close to 30% over the past 12 months.
Neither Shell nor BP have commented on the media and market speculation.
Shell's CEO Wael Sawan told analysts on the Q1 earnings call last week that 'before we ever look at a sizable inorganic, we have to have our own house in order.'
'I've said in the past we want to be value hunters. Today value hunting, in my view, is buying back more Shell,' Sawan said.
Still, market analysts and investment banks have started to run the numbers on how big a Shell-BP oil and gas giant could be.
For sure, a combined group would have nearly 5 million barrels of oil equivalent per day (boepd) in oil and gas production, UBS has estimated.
It would be the world's biggest investor-owned oil and producer, outpacing ExxonMobil, whose worldwide oil-equivalent production was 4.55-4.6 million boepd in the past two quarters. Chevron's net oil-equivalent production was 3.353 million boepd in the first quarter. That's higher than Shell's 2.7 million boepd, but it could be dwarfed by a combined Shell-BP producer.
A Shell-BP merger will also materially increase Shell's already number-one global position as the top LNG trader.
However, a potential transaction would face high execution and regulatory risks, analysts also say.
'We think the combination of BP's debt, hybrids, lease commitments and Macondo liabilities would present something of a poisoned chalice for Shell, a company that has typically been conservative with its balance sheet,' analysts at RBC said, as carried by Bloomberg.
Even if Shell were to decide that the potential gains from a BP deal would be worthwhile and opted to break its fiscal discipline, a giant Shell-BP company would face regulatory scrutiny in a number of jurisdictions, beginning with the UK North Sea. A megadeal would result in asset sales, too, according to analysts. One reason would be competition concerns in some markets as the combined Shell-BP share would be too big to ignore—and any regulatory approval could be conditional on sales of assets.
There may be solid rationales for a Shell-BP deal, but the reward may not be worth the risk.
By Tsvetana Paraskova for Oilprice.com
More Top Reads From Oilprice.comUS Crude Oil Output to Peak Sooner Than Expected
The Market Is Well Supplied - So Why Is Saudi Arabia Raising Oil Prices?
Read this article on OilPrice.com

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Oil-Dri Corp of America (ODC) Q3 2025 Earnings Call Highlights: Record Net Income and Strategic ...
Net Income: $11,644,000 for the quarter, surpassing all but 8 of the company's 84 prior fiscal years. Capital Expenditure: Expected to be around $32 million for the year, with a similar amount planned for the next year. Dividend Increase: 16% increase in quarterly dividends, marking the 22nd consecutive year of increased dividends. Net Cash from Operating Activities: $55 million year-to-date as of April 30, a 49% increase compared to the first nine months of fiscal year 2024. Effective Tax Rate: Estimated at 18% for Q3 FY2025, compared to 23% in Q3 FY2024. Capital Investment: $24.5 million invested year-to-date in fixed assets and mobile equipment. Ultra Pet Acquisition: Funded with $24 million in cash, $10 million in short-term financing, and $10 million in long-term financing; short-term financing has been paid off. Warning! GuruFocus has detected 8 Warning Sign with ODC. Release Date: June 06, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Oil-Dri Corp of America (NYSE:ODC) reported a net income of $11.6 million, surpassing all but 8 of its previous 84 fiscal years. The company has significantly increased its capital investment, planning to spend $143 million from fiscal 2022 to 2026, compared to $78 million in the previous five years. A 16% increase in quarterly dividends was announced, marking the 22nd consecutive year of dividend growth. The Ultra Pet acquisition has performed well, meeting internal financial benchmarks and achieving stronger than expected cost synergies. Oil-Dri Corp of America (NYSE:ODC) has secured new business in the renewable diesel sector, contributing to a 13% increase in this area despite a market downturn. Animal health and nutrition revenues were flat year-over-year for the quarter, affected by tariff issues and logistics challenges. The Ultra Legacy business experienced softer top-line performance, partially offset by successful distribution drives. The company lost a significant private label clay cat litter account, impacting distribution and sales. Natural gas prices are expected to rise, posing a challenge for production costs, with limited alternatives available. The Ultra Pet crystal cat litter business faces tariff pressures, affecting margins and requiring careful management of pricing strategies. Q: Although animal health and nutrition revenues were up year-over-year, they were flat this past quarter. Was this due to seasonality or changes in customer order patterns? A: Wade Robey, Vice President of Agriculture and President of Amlan International, explained that the flat performance was due to volatility caused by the tariff situation and longer transit times. Despite this, the year-to-date performance is on track, and they expect to finish the year meeting their targets. Q: The US renewable diesel production was down, yet Oil-Dri's was up 13%. How did this happen? A: Bruce Patsey, Vice President of the Fluids Purification Division, noted that new plants in the renewable diesel sector came online, and Oil-Dri secured new business from these plants. Additionally, they gained new customers in the vegetable oil segment, contributing to their growth. Q: What are the prospects for growing private label clay cat litter distribution and sales after losing a significant account? A: Laura Scheland, Vice President - Strategic Partnerships, stated that despite losing an account, they continue to have a strong share in the lightweight litter segment. They are targeting national retailers who don't carry their products and are optimistic about growth prospects in the private label lightweight business. Q: With natural gas prices expected to rise, are there alternatives to reduce operating costs at the plant level? A: Aaron Christiansen, Vice President of Operations, mentioned that while they have explored alternative fuels and drying technologies, natural gas remains the most cost-effective option. They are continuously optimizing fuel consumption and exploring new technologies to improve efficiency. Q: Is artificial intelligence playing a role in controlling expenses or targeting advertising? A: Susan Kreh, Chief Financial Officer, stated that they are at the beginning of their AI journey, using it to supplement team efficiency in areas like customer service and accounts payable. They have a five-year roadmap to further integrate AI for expense control. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Se produjo un error al recuperar la información Inicia sesión para acceder a tu portafolio Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información Se produjo un error al recuperar la información
Yahoo
an hour ago
- Yahoo
MustGrow Biologics Corp (MGROF) Q1 2025 Earnings Call Highlights: A Promising Start with ...
Sales Revenue: $3.8 million for Q1 2025. Gross Profit: Approximately $540,000. Gross Margin: 14.3%. Cash Position: $2 million. NexusBioAg Sales: Historical sales between $15 million to $20 million, with expectations to maintain this range. Shares Outstanding: 52 million shares, 59 million fully diluted. Warning! GuruFocus has detected 5 Warning Signs with MGROF. Release Date: May 28, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. MustGrow Biologics Corp (MGROF) reported $3.8 million in sales revenue for Q1 2025, marking a significant milestone as their initial sales numbers. The company successfully integrated NexusBioAg, a sales and distribution division, which contributed to the Q1 sales. MustGrow Biologics Corp (MGROF) has a strong partnership with Bayer, which includes a commercial agreement in Europe, Middle East, and Africa, with potential for milestone and royalty payments. The company holds 112 patents, showcasing a robust intellectual property portfolio, and is actively working on new IP generation. MustGrow Biologics Corp (MGROF) is focusing on a high-growth, asset-light model, with a tight capital structure and plans to drive revenue and margin growth. The gross margin for Q1 2025 was 14.3%, which was negatively affected by foreign exchange fluctuations and tariffs. Sales for TerraSante have not yet ramped up significantly, with expectations for more meaningful sales in late 2025 or early 2026. The company faces challenges with the registration process for TerraMG, with potential registration not expected until 2026. MustGrow Biologics Corp (MGROF) is assessing the need for additional working capital to drive revenue growth, indicating potential financial constraints. The agricultural market's seasonality and cyclicality present challenges in sales predictability and revenue generation. Q: Sales so far were all from Canada, right? Were any of them from TerraSante? A: Yes, Q1 sales were all in Canada, specifically through NexusBioAg. TerraSante sales in the US are expected to ramp up in the second half of this year. Q: How have tariffs affected sales, specifically for TerraSante? A: Our products were not directly affected by tariffs, but there were indirect effects such as a weaker Canadian dollar, which negatively impacted margins. Q: Are you able to provide any sort of a forecast for TerraSante? A: No, we do not provide forecasts at this time. Q: Is the regenerative or natural input market for agriculture growing faster than traditional inputs? A: Yes, the regenerative agriculture market is growing at a significant double-digit CAGR compared to the single-digit growth of the synthetic market. Q: When do you expect to see positive free cash flow? A: Our goal is to achieve positive cash flows next year, potentially into 2027, by driving revenues and margins. Q: Do you need more working capital for inventory to drive your revenues? A: Yes, we are assessing access to capital, including non-dilutive options, to support revenue and margin growth. Q: Are there any updates on the registration process for TerraMG? A: In North America, we are progressing with registrations and hope to have them by 2026. Bayer is also working on registrations in Europe, the Middle East, and Africa. Q: Does NexusBioAg only focus on Western Canada, or do they have a presence in Eastern Canada as well? A: NexusBioAg has coverage across Canada, with significant operations in both Western and Eastern Canada. Q: Are there any more impactful products in the pipeline to run through Nexus? A: Yes, there are many products in the pipeline, and we are leveraging Nexus's market access and relationships to introduce them. Q: Is there a push to open up or get approval in more US states? A: Currently, we are focusing on accelerating sales in California, Washington, Oregon, and Idaho, with potential expansion to other states being assessed. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Quanex Building Products Corp (NX) Q2 2025 Earnings Call Highlights: Record Sales Surge and ...
Net Sales: $452.2 million in Q2 2025, up 70% from $266.2 million in Q2 2024. Net Income: $20.5 million or $0.44 per diluted share in Q2 2025; adjusted net income of $27.9 million or $0.60 per diluted share. Adjusted EBITDA: Increased by 54.7% to $61.9 million in Q2 2025 from $40 million in Q2 2024. North American Fenestration Segment Sales: $151 million in Q2 2025, a decrease of 5.5% from $159.8 million in Q2 2024. European Fenestration Segment Sales: $61.3 million in Q2 2025, up 8.3% from $56.5 million in Q2 2024. North American Cabinet Component Segment Sales: $51.2 million in Q2 2025, compared to $51.1 million in Q2 2024. Tyman Business Sales: $190.1 million in Q2 2025. Cash Flow from Operations: $28.5 million in Q2 2025, compared to $33.1 million in Q2 2024. Free Cash Flow: $13.6 million in Q2 2025. Leverage Ratio: Net debt to last 12 months adjusted EBITDA at 3.2 times; debt covenant leverage ratio at 2.7 times. Share Repurchase: Approximately $23.5 million of stock repurchased in Q2 2025. Cost Synergies: Expected to realize $45 million over time, a 50% increase from the original target. Guidance: Reaffirmed net sales guidance of $1.84 billion to $1.86 billion and adjusted EBITDA guidance of $270 million to $280 million for fiscal 2025. Warning! GuruFocus has detected 3 Warning Signs with NX. Release Date: June 06, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Quanex Building Products Corp (NYSE:NX) reported a significant increase in net sales, reaching $452.2 million in Q2 2025, a 70% rise compared to the same period in 2024, primarily driven by the Tyman acquisition. The integration of the Tyman acquisition is progressing well, with cost synergies expected to reach $45 million, a 50% increase from the original target. The company has successfully localized supply chains to mitigate tariff impacts, with 22% of total cost of goods sold exposed to tariff risk, but USMCA compliance reduces this risk for Mexico and Canada. Quanex Building Products Corp (NYSE:NX) repurchased approximately $23.5 million of its stock in Q2 2025, taking advantage of a low share price and maintaining a healthy balance sheet. The company reaffirmed its net sales guidance of $1.84 billion to $1.86 billion and adjusted EBITDA guidance of $270 million to $280 million for fiscal 2025, indicating confidence in future performance. Despite the overall sales increase, net sales excluding the Tyman contribution declined by 1.4% in Q2 2025, largely due to lower volume in North America. The North American fenestration segment saw a 5.5% decrease in net sales, with volumes declining by approximately 7% year over year. Consumer confidence in North America and Europe is negatively impacted by higher interest rates and geopolitical tensions, affecting market conditions. Pricing pressures continue in Europe, although operational performance has helped offset price concessions. Free cash flow was impacted by one-time items related to integration costs and achieving cost synergies, resulting in $13.6 million for the quarter. Q: Can you give a little more color on raising the synergy target from $30 million to $45 million, and is there potential beyond that? A: George Wilson, CEO, explained that the increase in synergy targets is due to the efficiency and opportunities identified in the new operating segments. These include headcount reductions and sourcing synergies. While revenue synergies are still early, the team is confident in further potential as they continue to refine their strategies. Q: Is the tariff situation an opportunity for Quanex given your domestic manufacturing footprint, and are you seeing bids related to increased domestic sourcing? A: George Wilson, CEO, noted that their structured supply chain and diverse geographic footprint have indeed provided opportunities. They have seen increased quoting and execution of spot purchases, particularly in the cabinet segment, as customers seek to mitigate supply chain risks. Q: Where in the Tyman portfolio have you realized cost synergies faster than expected? A: Scott Zuehlke, CFO, highlighted that the main synergies came from procurement and corporate functions such as finance, HR, and IT. The integration of teams revealed more opportunities than initially estimated. Q: Is the $6.5 million in intangible asset amortization realized in Q2 a good quarterly run rate, and what is the full-year expectation for D&A? A: Scott Zuehlke, CFO, confirmed that the Q2 figure is a reasonable run rate. The company initially guided around $60 million for adjusted D&A for the year, excluding intangible amortization, which remains a good estimate. Q: Can you provide more details on the impact of tariffs on your cost of goods sold? A: George Wilson, CEO, stated that approximately 22% of their total cost of goods sold is exposed to tariff risk, with 13% specific to Mexico and Canada. However, being USMCA compliant, the tariff rate is essentially zero for these countries, minimizing potential margin impacts. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus.